Zobrazeno 1 - 10
of 10
pro vyhledávání: '"De Yun Luo"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Fruquintinib is a third-line and subsequent targeted therapy for patients with metastatic colorectal cancer (mCRC). Identifying survival predictors after fruquintinib is crucial for optimizing the clinical use of this medication. Objectiv
Externí odkaz:
https://doaj.org/article/529a581f9f254d13bb115aa02a344c22
Publikováno v:
Clinical Case Reports, Vol 10, Iss 2, Pp n/a-n/a (2022)
Abstract Penile squamous cell carcinoma with pelvic lymph node metastases/recurrence has a poor prognosis. We reported a case with recurrent pSCC was administered cetuximab and anlotinib after failure of first‐line treatment and achieved an effecti
Externí odkaz:
https://doaj.org/article/e77a39db486f490b9cf08bfc10346a9d
Autor:
Yue-Ting Zhu, Xin-Zu Chen, Ye Chen, Yu-Wen Zhou, Lian-Sha Tang, De-Yun Luo, Qiu Li, Meng Qiu, Xin Wang, Dan Cao, Yu Yang, Ya-Li Shen, Zhi-Ping Li, Feng Bi, Ji-Yan Liu, Hong-Feng Gou
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundSignet ring cell containing gastric cancer (SRCGC) is a rare subtype of gastric cancer, and its adjuvant therapy is based on general gastric cancer. However, the effectiveness of radiotherapy for those SRCGC patients remains unknown.Purpose
Externí odkaz:
https://doaj.org/article/0e1e71e211f2493fa05888e637fad408
Autor:
Zhi-Qiang Wang, Dong-Sheng Zhang, Nong Xu, De-Yun Luo, Yan-Hong Deng, Feng-Hua Wang, Hui-Yan Luo, Miao-Zhen Qiu, Yu-Hong Li, Rui-Hua Xu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-7 (2016)
Abstract Background Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer. This phase II study was conducted to evaluate the efficacy and safety of the combination of S-1, oxaliplatin, and leucovorin (SOL) in the treatm
Externí odkaz:
https://doaj.org/article/41848663e2764de0b58a1693aa362e52
Autor:
Feng Xu, Jian Zang, Hong Feng Gou, Min Hou, Feng Bi, Cheng Yi, Dan Cao, Jing Wang, YaLi Shen, Xiao Juan Zhou, Ming Jiang, Meng Qiu, Yu Yang, De Yun Luo
Publikováno v:
Supportive Care in Cancer. 19:667-673
Several trials had independently noted that patients receiving megestrol acetate had less nausea and vomiting, but this antiemetic activity of megestrol acetate has not been reported separately in the literature. Our objective was to evaluate the ant
Autor:
De Yun Luo, Yuan Kai Shi, Yiping Zhang, Wei Jing Zhang, Xiao Hui He, Yunpeng Liu, Qiang Chen, X Y Ke, Jianmin Wang, Xiao Qing Liu, Yun Zhong Zhu, Jian Hua Chang, An Lan Wang, Yang Zhang, Wei Lian Li, Xiu Wen Wang, Hua Qing Wang, Ze Fei Jiang
Publikováno v:
Anti-cancer drugs. 24(6)
The purpose of this study was to compare the efficacy and safety of a single subcutaneous injection of pegylated filgrastim with daily filgrastim as a prophylaxis for neutropenia induced by commonly used chemotherapy regimens. Fifteen centers enrolle
Autor:
Yuan-kai, Shi, Xiao-hui, He, Sheng, Yang, Hua-qing, Wang, Ze-fei, Jiang, Yun-zhong, Zhu, Xiao-yan, Ke, Yang, Zhang, Yun-peng, Liu, Wei-jing, Zhang, Zhao, Wang, Qing-zhi, Shi, Xiao-dong, Xie, He-long, Zhang, Jie-jun, Wang, De-yun, Luo, Qing-shan, Zheng, Rui-yuan, Sun
Publikováno v:
Zhonghua yi xue za zhi. 86(48)
To compare the efficacy and safety of daily administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF), and a single subcutaneous injection of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF), a
Publikováno v:
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. 37(6)
To investigate the association of expression of Cat V with the clinicopathologic variables of myasthenia gravis (MG) in patients with thymoma.Seventy-eight patients with thymomas were involved. Immunohistochemical method was adopted in investigating
Publikováno v:
Oncology Letters; May2016, Vol. 11 Issue 5, p3501-3507, 7p
Autor:
Miao Zhen Qiu, Hui Yan Luo, Zhi Qiang Wang, Yu Hong Li, Yan Hong Deng, Feng Hua Wang, Dong Sheng Zhang, Rui-Hua Xu, De Yun Luo, Nong Xu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-7 (2016)
Chinese Journal of Cancer
Chinese Journal of Cancer
Background Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer. This phase II study was conducted to evaluate the efficacy and safety of the combination of S-1, oxaliplatin, and leucovorin (SOL) in the treatment of Ch